Company
ChinaWeiwei Ouyang, Guiyang, China – FDA Inspections
Inspection records and compliance data for Weiwei Ouyang in Guiyang. 1 FDA inspection on record, 1 Form 483, last inspected June 18, 2026.
Company Profile
This profile covers Weiwei Ouyang based in Guiyang, China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected June 18, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 18, 2026 | Not classified | Human Drugs | 1326180 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Huangshi Meifeng Chemical Co. Ltd.
Shusuan Jiang, M.D.
Huadong Medicine Co., Ltd.
Huayi Isotopes Company
Northeast Pharmaceutical Group Co., Ltd.
Suzhou Pharmaceutical Technology Co.,Ltd
China Resources Zizhu Pharmaceutical Co., Ltd.
Fuan Pharmaceutical Group Chongqing Bosen Pharma. Co., LTD
Zhejiang Xianju Xianming Pharmaceutical Co., Ltd.
Zhongjun Xia, MD
Company Information
Name
Weiwei Ouyang
FEI Number
3043995624
Address
The Affiliated Cancer Hospital Of Guizhou Medical University - General Campus, 219 Baiyun Avenue; Yunyan District, Guiyang, China
Country
China
ID: 8036c852-cc9e-4218-a72c-fe086abb793b